Main description:

Explaining the assessment of potential drug compounds, this is an ideal introductory reference for those new to drug discovery. It includes sections on pharmacokinetics and drug metabolism, integration of pharmaceutical development, and predictive safety assessment. Topics include: cost analysis, drug transporters, cytochrome P-450 and drug-drug interactions, plasma protein binding, assessing stability, ways to optimize drug formulation, toxicology and toxicokinetics, and more. Readers will understand why absorption-distribution-metabolism-excretion-toxicology (ADMET) is key in drug development. This is an enlightening reference for scientists, medicinal chemists, and others working in drug discovery.

Contents:

PREFACE. CONTRIBUTORS. 1. INTRODUCTION (Charles B. Davis). 2. PHARMACOKINETICS IN PRECLINICAL DRUG DEVELOPMENT: AN OVERVIEW (Dion Brocks). 3. THE ROLE OF MEMBRANE TRANSPORTERS IN DRUG DISPOSITION (Fanfan Zhou, Peng Duan, and Guofeng You). 4. CYTOCHROME P450: STRUCTURE, FUNCTION, AND APPLICATION IN DRUG DISCOVERY AND DEVELOPMENT (Ramesh B. Bambal and Stephen E. Clarke). 5. THE ROLE OF DRUG METABOLISM AND METABOLITE IDENTIFICATION IN DRUG DISCOVERY (Xiangming Guan). 6. PROTEIN BINDING IN DRUG DISCOVERY AND DEVELOPMENT (Vikram Ramanathan and Nimish Vachharajani). 7. PREDICTION OF THE PHARMACOKINETICS IN HUMANS (Chao Han and Ramesh Bambal). 8. PHARMACEUTICS DEVELOPABILITY ASSESSMENT (Lian Huang, Jinquan Dong, and Shyam Karki). 9. SAFETY ASSESSMENT IN DRUG DISCOVERY (Vito G. Sasseville, William R. Foster, and Bruce D. Car). 10. ASSESSMENT OF STRATEGIES UTILIZED TO MINIMIZE THE POTENTIAL FOR INDUCTION OF ACQUIRED LONG QT SYNDROME AND TORSADE DE POINTES (Khuram W. Chaudhary and Barry S. Brown). INDEX.